Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clinical implications of late gadolinium enhancement in patients with active cancer undergoing stress CMR

Cardiovascular disease and cancer are the two leading causes of mortality worldwide. (1) Advances in oncologic therapies have improved cancer survival, resulting in a growing population of patients with active malignancy or cancer survivors who remain at increased risk of cardiovascular and non-cancer mortality....

A. Afana, S. Duhamel, S. Toupin et al. · 0 citations
Aug 2026

ICARE-TNBC : Immune checkpoint-associated cardiotoxicity risk evaluation in early-stage triple-negative breast cancer

In patients with early-stage TNBC treated with pembrolizumab, cardiotoxicity was frequent and associated with a significant reduction in overall survival, and larger prospective studies are required to better characterise predictors of cardiotoxicity in this setting.

L. Dib, B. Sibila, C. Regragui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.